This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
Connecting Innovators with Strategic Knowledge & Capital
September 16th - 17th, 2025Boston, MA, USA
Book Now
Menu
Book Now
Key Sessions
Simone Mori
Globalization to Deliver Comprehensive Early Clinical Data to Mitigate the Current Biotech Investment Benchmarks
Moderna
Luba Greenwood
The CVC Perspective: Strategic Venturing in Biotech Throughout 2024 & Beyond
Dana-Farber Cancer Institute
Maha Radhakrishnan
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
Sofinnova Investments
Michelle Li
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
Bristol Myers Squibb
Tadaaki Taniguchi
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
Astellas Pharma
Hong Chen
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
Novo Nordisk
keyboard_arrow_right

Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
search
8:00am - 9:00am
Registration & Breakfast
Showing 3 of 3 Streams
9:00am - 9:05am
LSX Welcome Address
  • Adam Griffiths - Senior Director, Biotech Lead, Informa
9:05am - 9:30am
Assessing Biotech Investment Trends in 2024 and Beyond
  • Cody Powers - Partner, ZS Associates
9:30am - 10:10am
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
  • Maha Radhakrishnan - Executive Partner, Sofinnova Investments
  • Chris Jeffers - SVP, Life Sciences, Brown Rudnick
  • Jim MacKrell - VP Lilly Venture Science, Eli Lilly
  • Issi Rozen - General Partner, Google Ventures
  • Richard Kivel - CEO, Graybella Capital
  • Bibhash Mukhopadhyay - Managing Partner & Co-Founder, Sound Bioventures
10:10am - 10:30am
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
  • Tadaaki Taniguchi - Chief Medical Officer, Astellas Pharma
  • Christina Corridon - Managing Principal, ZS
10:30am - 11:00am
Morning Break
9:00am - 9:10am
LSX Welcome Address
  • Jack Giles - Conference Producer, LSX
9:10am - 9:50am
Sustained Success - A Holistic Review of MedTech in 2024
  • Marissa Fayer - CEO, DeepLook Medical
  • Carla Peron - Chief Medical Officer, Philips
  • Joseph Smith - CSO, BD
  • Mahala Burn - VP, Corporate Development, bioMérieux
  • Brian Montgomery - Chief Strategy Officer, GE HealthCare
9:50am - 10:30am
Promises in Pixels - Evaluating AI's Impactful Delivery
  • Jeff Chu - Managing Partner, Features Capital
  • Susan Wood - CEO, Vida Diagnostics
  • Karen Holzberger - President & CEO, SpinTech MRI
  • Chris Ciriello - CEO & Co-Founder, Perceptive
  • Sanjay Parekh - Global Strategy Business Development, Perspectum
10:30am - 11:00am
Morning Break
9:00am - 9:10am
LSX Welcome Address
  • Nadia Konneh - Senior Conference Director, Healthtech Lead, LSX
9:10am - 9:50am
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
  • Ziv Bar-Joseph - VP, Head, R&D Data & Computational Sciences, Sanofi
  • Amir Zur - Former Executive Director, Head of R&D Digital Head Products, Takeda
  • Shweta Maniar - Global Director Health & Life Sciences, Google
  • Antonio Regalado - Biomedicine Editor, MIT Technology Review
  • Jane Yan - COO & Chief Product Officer, LunaJoy Health
  • Kaushik Gune - President, EVP, Huma US
9:50am - 10:30am
DTx 2.0 – Building the Right Digital Therapeutic Business Model for Long-Term Growth & Revenue
  • Joe Perekupka - CEO, Freespira
  • David Klein - CEO, Click Therapeutics
  • Andy Molnar - CEO, Digital Therapeutics Alliance
  • Adam Pellegrini - CEO, Kaia Health
10:30am - 11:00am
Morning Break
Showing 5 of 5 Streams
11:00am - 11:40am
The Venture Investor Outlook and Investing in the Therapies of Tomorrow
  • Jeff Quillen - Partner, Foley Hoag
  • Dirk Landgraf - Partner, SV Health Investors
  • Evan Caplan - Principal, OrbiMed
  • Eric Snyder - Partner, Venture Investments, Novo Holdings
  • Rebecca Luse - Principal, Deep Track Capital
  • Ralf Saykiewicz - Managing Partner, Raudi Capital
11:40am - 12:00pm
Globalization to Deliver Comprehensive Early Clinical Data to Mitigate the Current Biotech Investment Benchmarks
  • Simone Mori - Head, External Research Venture, Moderna
  • Chris Hickey - CBO, Nucleus Networks
  • Kiran Reddy - Senior Managing Director, Blackstone LIfe Sciences
  • Biljana Georgievska - CCO, Nucleus Networks
12:00pm - 12:40pm
Understanding Shifts in Early-Stage VC Investment Criteria
  • Lynn Lewis - Founder & CEO, Gilmartin Group
  • Stephen Bruso - Partner, Morningside Advisory
  • John Boyce - Managing Director & Co-Founder, TigerGene
  • Reetika Bhardwaj - Senior Associate, ARCH Venture Partners
11:00am - 11:40am
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
  • Hong Chen - Director, Search & Evaluation USA, Novo Nordisk
  • Hannah England - Partner, Ropes & Gray
  • Mankit Law - Director - BD, Search & Evaluation, GSK
  • Jeremy O’Hanlon - Executive Director, Global BD, Daiichi-Sankyo
  • Greg Fralish - CBO, GlycoEra
11:40am - 12:00pm
Partnering Globally: Enabling Different Strategies and Approaches to Drive Innovation
  • Andrew Whittle - Director, BD&L, Boehringer Ingelheim
12:00pm - 12:40pm
Driving Innovation in Life Sciences Through Fostering Strong Partnerships Between Industry, Academia, and NPOs
  • Alison Fenney - Executive Director, Strategic Partnerships and Business Operations, Regeneron Genetics Center
  • Alfred Slanetz - Chairman, National Foundation for Cancer Research
  • James Zanewicz - Chief Strategy Officer, Tulane University
  • Peter Meinke - Sanders Director, Tri-Institutional Therapeutics Discovery Institute
  • Jukka Muhonen - President, AllianceXConsulting
11:00am - 11:40am
Funding Biotech Innovation and Scaling Up
  • Kyle DiLella - Team Lead, Emerging Corporate Life Sciences, Citibank
  • Ellen Donnelly - CEO, Abliva
  • Ann Belien - CEO & Founder, Rejuvenate Biomed
  • Daniel Janse - CEO, AffyImmune
  • Dan Passeri - CEO, Cue Biopharma
  • Rachel Ravens - CEO, 42Genetics
11:40am - 12:00pm
Accelerating Cures: Speeding Up Clinical Trials to Maximize Returns For All
  • Ben van der Schaaf - Partner, Arthur D. Little
  • Ben Enejo - Partner, Arthur D. Little
12:00pm - 12:40pm
Integrating CMC Development for Value Creation in Biotech Start-Ups
  • Zeid Barakat - Partner, Scimitar
  • Johannes Roebers - Head of Business Development Unit, ProductLife Group
  • Dan Jacobs - VP, CMC Operations, Flagship Pioneering
  • Chase Orsello - Global Head Bioprocess Development, Sanofi
  • Neera Jain - Vice President, Chemical Pharmaceutical Development & Operations, Syros Pharmaceuticals
  • Federico Pollano - SVP, Business Development, Rentschler
11:00am - 11:50am
Keeping The Cash Flow - Sustaining Momentum Through Maturation
  • Rowan Walrath - Life Sciences Reporter, C&EN, American Chemical Society
  • Darshana Zaveri - Managing Partner, Catalyst Health Ventures
  • Karthik Bolisetty - Senior Associate, Gilde Healthcare
  • Jed Cohen - Managing Director, Medical Technology Investment Banking, Raymond James
  • Sean Cheng - Managing Director, Ascension Ventures
11:50am - 12:40pm
Rulebooks & Revenue - Winning Strategies For US Medtech Compliance & Market Access
  • Julie Lankiewicz - Director, Global Clinical Strategy - Orthopaedics, Robotics and Digital Health/Enabling Technologies, Smith+Nephew
  • Karen Cross - Co-Founder & CEO, MIMOSA Diagnostics
  • John Konsin - CEO & Co-Founder, Prapela
  • Christy Sheehy-Bensinger - CEO & Founder, C-Light Technologies
  • Shaherah Yancy - CEO & Founder, Research Lifecycle Solutions
  • Giles Hamilton - Operating Partner, New Growth Advisors
11:00am - 11:50am
Streamlining Clinical Trials for Patients & Clinicians Through Digital
  • John Wagner - Chief Medical Officer, Koneksa
  • Jodi Akin - Founding CEO, Hawthorne Effect
  • Sarah Valentine - Partnerships Lead, Life Sciences, Digital Medicine Society (DiMe)
  • Ben Casavant - Co-Founder & CEO, Tasso
  • Ritesh Patel - Senior Director, Global Digital Health, FINN Partners
11:50am - 12:40pm
Overcoming Pharma & Medtech’s Digital Transformation Challenges – How to Change for Real?
  • Saurav Gupta - Senior Director, Platform Strategy & Implementation – Connected Care, Eli Lilly
  • Nishtha Jain - Head of Innovation & Digital Technology, Takeda
  • Kevin McRaith - President & CEO, Welldoc
  • Jonah Comstock - Editor in Chief, pharmaphorum
12:40pm - 1:40pm
Lunch Break
Showing 5 of 5 Streams
1:40pm - 2:30pm
Building Strong Biotech Foundations: Governance, Growth, and Fundraising Strategies
  • Doug Locke - CEO, SSI Strategy
  • Madhav Gurijala - SVP Business Consulting, SSI Strategy
  • Steve Zelenkofske - Executive Advisor, SLZ Consulting
  • Björn Cochlovius - CEO, eleva
2:30pm - 3:20pm
The CVC Perspective: Strategic Venturing in Biotech Throughout 2024 & Beyond
  • Luba Greenwood - Managing Partner, Binney Street Capital Venture Fund, Dana-Farber Cancer Institute
  • Marian Nakada - VP, Venture Investments, JJDC
  • Aaron Nelson - Managing Director, Novartis Venture Fund
  • Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
  • Irena Melnikova - Partner, Pfizer Ventures
1:40pm - 2:30pm
The Oncology Odyssey: Exploring New Market Trends In Cancer Research and Partnering
  • Alex Philippidis - Senior Business Editor, Genetic Engineering & Biotechnology News
  • Natalia Ulyanova - Business Development Director, Oncology, Astellas, USA
  • William Ho - President & CEO, IN8bio
  • Elizabeth Wood - Founder & CEO, JURA Bio
  • José Mejía Oneto - CEO, Shasqi
  • Tim Sullivan - CBO, Infinimmune
2:30pm - 3:20pm
Key Stakeholders in Building a Robust Women’s Health Ecosystem
  • Anula Jayasuriya - Co-Founder, Kidron Capital
  • Elizabeth Garner - President, KNI Health Consultants
  • Elizabeth Bailey - Managing Director, RH Capital
  • Lori Frank - President, WHAM
  • Allison Watkins - Founder & CEO, Watkins-Conti Products, Inc
  • Gerardo Toledo - CEO & Co-founder, Solarea Bio
1:40pm - 2:30pm
Commercialization Strategies for Biotechs and Early-Planning
  • Joe Goldberg - Partner, RSM US LLP
  • Dan Oliver - CEO, Rejuvenate Bio
  • Michelle Chen - CBO, Insilico Medicine
  • Jeff Landau - CBO, CytomX
  • Sohail Zaidi - CEO, Ananda Scientific
2:30pm - 3:20pm
Developing an Effective Message and Strategic Positioning in a Crowded Market
  • David Brower - CBO, Accent Therapeutics
  • Jae Won Kim - COO & CFO, VantAI
  • Kimberly Ha - Founder & CEO, KKH Advisors
  • Michael Goldberg - CEO, Surge Therapeutics
  • Regina Salvat - Principal, Sofinnova Investments
1:40pm - 2:30pm
Ctrl+Challenge – SaaMD Pathways and Pitfalls
  • Sheena Dempsey - Chief Solutions Officer, Indivi
  • Cathy Skinner - CEO, NXgenPort Inc
  • Kevin Stevens - Head, Global Regulatory Affairs Device, PDT, Takeda
  • Arvind Ramadorai - Global Head of Innovation, Robotic Surgery Technologies, Medtronic
  • Shruti Choudhary - SVP, Product, Elucid
2:30pm - 3:20pm
Access Granted - Strategies For Successful Market Entry
  • Christine Horton - CEO, Visura Technologies
  • Nishant Doctor - CEO, Surf Therapeutics
  • Marc Jones - CEO, Altoida
  • Kristen Hedstrom - VP, Market Access & Professional Education, Integra LifeSciences
  • Ryan McGuinness - Commercial General Manager, Triple Ring Technologies
1:40pm - 2:30pm
Healthtech Business Scale Up - Setting Healthtech Companies up for Success
  • Sam Oddson - Chief Medical Officer, Sidekick Health
  • Patricia Bradley - Global CCO, MindMaze
  • Katerina Fialkovskaya - Venture Investor, Philips Ventures
  • Yasir Drabu - Founder & CEO, Taazaa
  • Gemma Wenstrom - COO, Kaia Health
  • Sunnie Southern - Founder & CEO, Viable Synergy
2:30pm - 3:20pm
Building Sustainable, Value-Based Strategic Digital Health Partnerships
  • Catherine Blanchette - VP & Head of Digital Strategic Partnerships, Sanofi
  • Ameya Phadke - Patients Non-Pharma Solutions Leader, Chiesi
  • Nathan Sundheimer - Former Head, US Healthcare Partnerships, Plug and Play
  • Jin Lee - Founder & CEO, IMIDeology
  • Abhay Kakde - Director, Global Strategy & Operations, AstraZeneca
3:20pm - 3:50pm
Afternoon Break
Showing 3 of 3 Streams
3:50pm - 4:30pm
Maximizing Returns: Unleashing the Power of AI for Tangible ROI
  • Mark Stead - Head of BD, Atomic AI
  • Greg Ryslik - CTO, COMPASS Pathways
  • Elizabeth Schwarzbach - CBO, BigHat Biosciences
  • Ben Hohn - Principal, BD, Pipeline and Launch Strategy, ZS Associates
  • Kfir Schreiber - CO-founder & CEO, DeepCure
4:30pm - 4:50pm
Forging Alliances and Leveraging Acquisitions to Generate Shared Value for Patients, People, Communities, the Planet and Thriving as Business
  • Stefano Cottignoli - Head of Global Business and Corporate Development, Chiesi Group
4:50pm - 5:00pm
Biopharma Partnering Benchmarking Report
  • Michael Rai - General Manager, partneringONE
  • Millie Nelson - Editor, BioXconomy, Informa Connect Life Sciences
5:00pm - 5:40pm
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
  • Michelle Li - Vice President and Head, BD&L Transactions, Bristol Myers Squibb
  • Nicole Daley - Partner, A&O Shearman
  • Philippe Lopes-Fernandes - EVP, CBO, Ipsen
  • Dave Moore - EVP, Coporate Development, Novo Nordisk
  • Sarah Kilpatrick - VP Business Development, Pfizer
  • Issei Tsukamoto - SVP, Global Head Business Development, Astellas
3:50pm - 4:40pm
Strategic Synergies: Scaling Through Industry Collaboration
  • JoJo Platt - Senior Contributing Editor, Neurotech Reports
  • Kurt Haggstrom - CCO, Synchron
  • Ana Maria Maiques Valls - CEO, Neuroelectrics
  • Anh Hoang - CEO, Jana Care
  • Jonathan Hoyt - Executive Director, Global Market Development, Olympus Corporation of the Americas
4:40pm - 5:30pm
Put It On Your Pitchdeck - Meeting Investor Expectations
  • Michael Bison - Partner, Goodwin
  • Scott Gazelle - Co-Founder & Managing Partner, GreyBird Ventures
  • Amy Salzhauer - Founder & Managing Partner, Good Growth Capital
  • Eddie Hanlon - Investment Manager, Gilde Healthcare
  • Jotthe Kannappan - Senior Associate, Intuitive Ventures
3:50pm - 4:40pm
AI Forward- Pursuing the Safe, Responsible and Meaningful Integration of Generative AI in Healthcare
  • Neil Sahota - CEO, ACSI Labs & AI Advisor, United Nations
  • Dale Cyr - CEO & Executive Director, Inteleos
  • Sheila Phicil - Director of Innovation, Boston Medical Center Health System
  • Julie O'Shaughnessy - COO, Vivodyne
4:40pm - 5:30pm
Time for Revival? Healthtech & Digital Health Investment
  • Jonathan Machado - Managing Director, Samsung NEXT
  • Tunde Akinniranye - Investor, 7wire Ventures
  • Ian Chiang - Partner, Flare Capital
  • Cheryl Cheng - Founder & CEO, Vive Collective
  • Austin Poole - Partner, BIP Ventures
5:40pm - 5:45pm
Close Of Day One Agenda – Drinks Reception
Forums and Workshop (September 12)
NextDay 2 – Thursday, 12 SEPTEMBER
Filter
Streams
Formats
Choose Day